[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global IBS-C Drug Industry Research Report 2020, Forecast to 2025

June 2020 | 134 pages | ID: GB3B11C0C9BEEN
WKinformation

US$ 2,560.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The IBS-C Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for IBS-C Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of IBS-C Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading IBS-C Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global IBS-C Drug market are discussed.

The market is segmented by types:
  • Linaclotide
  • Lubiprostone
  • Osmotic Laxatives
  • Stimulant Laxatives
  • Other
It can be also divided by applications:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
And this report covers the historical situation, present status and the future prospects of the global IBS-C Drug market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
  • Catalent Pharmaceuticals Solutions
  • Ardelyx
  • Synergy Pharmaceuticals
  • Nestle
  • Astellas Pharmaceuticals
  • Abbott Laboratories
  • Teva Pharmaceutical Industries
  • Novartis Pharma
  • Sucampo Pharmaceuticals
  • Synthetic Biologics
  • Norgine
  • Albireo Pharma
  • Bama-Geve
  • Astrazeneca
  • Prometheus Laboratories
  • Salix Pharmaceuticals
  • Ferring BV
  • Yuhan Corp
  • Actavis Nordic
  • Ironwood Pharmaceuticals
  • The Menarini Group
  • Ono Pharmaceutical
Report Includes:
  • xx data tables and xx additional tables
  • An overview of global IBS-C Drug market
  • An detailed key players analysis across regions
  • Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Insights into regulatory and environmental developments
  • Information on the supply and demand scenario and evaluation of technological and investment opportunities in the IBS-C Drug market
  • Profiles of major players in the industry, including Catalent Pharmaceuticals Solutions, Ardelyx, Synergy Pharmaceuticals, Nestle, Astellas Pharmaceuticals.....
Research objectives
  • To study and analyze the global IBS-C Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
  • To understand the structure of IBS-C Drug market by identifying its various subsegments.
  • Focuses on the key global IBS-C Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
  • To analyze the IBS-C Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of IBS-C Drug submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
Global IBS-C Drug Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 IBS-C Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 IBS-C DRUG INDUSTRY OVERVIEW

2.1 Global IBS-C Drug Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 IBS-C Drug Global Import Market Analysis
  2.1.2 IBS-C Drug Global Export Market Analysis
  2.1.3 IBS-C Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Linaclotide
  2.2.2 Lubiprostone
  2.2.3 Osmotic Laxatives
  2.2.4 Stimulant Laxatives
  2.2.5 Other
2.3 Market Analysis by Application
  2.3.1 Hospital Pharmacies
  2.3.2 Retail Pharmacies
  2.3.3 Online Pharmacies
2.4 Global IBS-C Drug Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global IBS-C Drug Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global IBS-C Drug Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global IBS-C Drug Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 IBS-C Drug Manufacturer Market Share
  2.4.5 Top 10 IBS-C Drug Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into IBS-C Drug Market
  2.4.7 Key Manufacturers IBS-C Drug Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 IBS-C Drug Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): IBS-C Drug Industry Impact
  2.7.1 How the Covid-19 is Affecting the IBS-C Drug Industry
  2.7.2 IBS-C Drug Business Impact Assessment - Covid-19
  2.7.3 Market Trends and IBS-C Drug Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 IBS-C Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL IBS-C DRUG MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global IBS-C Drug Sales Market Share by Region
4.2 Global IBS-C Drug Revenue Market Share by Region (2015-2019)
4.3 Global IBS-C Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America IBS-C Drug Market Size Detail
  4.4.1 North America IBS-C Drug Sales Growth Rate (2015-2020)
  4.4.2 North America IBS-C Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe IBS-C Drug Market Size Detail
  4.5.1 Europe IBS-C Drug Sales Growth Rate (2015-2020)
  4.5.2 Europe IBS-C Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan IBS-C Drug Market Size Detail
  4.6.1 Japan IBS-C Drug Sales Growth Rate (2015-2020)
  4.6.2 Japan IBS-C Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China IBS-C Drug Market Size Detail
  4.7.1 China IBS-C Drug Sales Growth Rate (2015-2020)
  4.7.2 China IBS-C Drug Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL IBS-C DRUG MARKET SEGMENT BY TYPE

5.1 Global IBS-C Drug Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global IBS-C Drug Sales and Market Share by Type (2015-2020)
  5.1.2 Global IBS-C Drug Revenue and Market Share by Type (2015-2020)
5.2 Linaclotide Sales Growth Rate and Price
  5.2.1 Global Linaclotide Sales Growth Rate (2015-2020)
  5.2.2 Global Linaclotide Price (2015-2020)
5.3 Lubiprostone Sales Growth Rate and Price
  5.3.1 Global Lubiprostone Sales Growth Rate (2015-2020)
  5.3.2 Global Lubiprostone Price (2015-2020)
5.4 Osmotic Laxatives Sales Growth Rate and Price
  5.4.1 Global Osmotic Laxatives Sales Growth Rate (2015-2020)
  5.4.2 Global Osmotic Laxatives Price (2015-2020)
5.5 Stimulant Laxatives Sales Growth Rate and Price
  5.5.1 Global Stimulant Laxatives Sales Growth Rate (2015-2020)
  5.5.2 Global Stimulant Laxatives Price (2015-2020)
5.6 Other Sales Growth Rate and Price
  5.6.1 Global Other Sales Growth Rate (2015-2020)
  5.6.2 Global Other Price (2015-2020)

6 GLOBAL IBS-C DRUG MARKET SEGMENT BY APPLICATION

6.1 Global IBS-C DrugSales Market Share by Application (2015-2020)
6.2 Hospital Pharmacies Sales Growth Rate (2015-2020)
6.3 Retail Pharmacies Sales Growth Rate (2015-2020)
6.4 Online Pharmacies Sales Growth Rate (2015-2020)

7 GLOBAL IBS-C DRUG MARKET FORECAST

7.1 Global IBS-C Drug Sales, Revenue Forecast
  7.1.1 Global IBS-C Drug Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global IBS-C Drug Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global IBS-C Drug Price and Trend Forecast (2020-2025)
7.2 Global IBS-C Drug Sales Forecast by Region (2020-2025)
  7.2.1 North America IBS-C Drug Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe IBS-C Drug Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan IBS-C Drug Production, Revenue Forecast (2020-2025)
  7.2.4 China IBS-C Drug Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF IBS-C DRUG INDUSTRY KEY MANUFACTURERS

8.1 Catalent Pharmaceuticals Solutions
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Catalent Pharmaceuticals Solutions IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Catalent Pharmaceuticals Solutions News
8.2 Ardelyx
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Ardelyx IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Ardelyx News
8.3 Synergy Pharmaceuticals
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Synergy Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Synergy Pharmaceuticals News
8.4 Nestle
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Nestle IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Nestle News
8.5 Astellas Pharmaceuticals
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Astellas Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Astellas Pharmaceuticals News
8.6 Abbott Laboratories
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Abbott Laboratories IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Abbott Laboratories News
8.7 Teva Pharmaceutical Industries
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Teva Pharmaceutical Industries IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Teva Pharmaceutical Industries News
8.8 Novartis Pharma
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Novartis Pharma IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Novartis Pharma News
8.9 Sucampo Pharmaceuticals
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Sucampo Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Sucampo Pharmaceuticals News
8.10 Synthetic Biologics
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 Synthetic Biologics IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 Synthetic Biologics News
8.11 Norgine
  8.11.1 Company Details
  8.11.2 Product Information
  8.11.3 Norgine IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.11.4 Main Business Overview
  8.11.5 Norgine News
8.12 Albireo Pharma
  8.12.1 Company Details
  8.12.2 Product Information
  8.12.3 Albireo Pharma IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.12.4 Main Business Overview
  8.12.5 Albireo Pharma News
8.13 Bama-Geve
  8.13.1 Company Details
  8.13.2 Product Information
  8.13.3 Bama-Geve IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.13.4 Main Business Overview
  8.13.5 Bama-Geve News
8.14 Astrazeneca
  8.14.1 Company Details
  8.14.2 Product Information
  8.14.3 Astrazeneca IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.14.4 Main Business Overview
  8.14.5 Astrazeneca News
8.15 Prometheus Laboratories
  8.15.1 Company Details
  8.15.2 Product Information
  8.15.3 Prometheus Laboratories IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.15.4 Main Business Overview
  8.15.5 Prometheus Laboratories News
8.16 Salix Pharmaceuticals
  8.16.1 Company Details
  8.16.2 Product Information
  8.16.3 Salix Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.16.4 Main Business Overview
  8.16.5 Salix Pharmaceuticals News
8.17 Ferring BV
  8.17.1 Company Details
  8.17.2 Product Information
  8.17.3 Ferring BV IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.17.4 Main Business Overview
  8.17.5 Ferring BV News
8.18 Yuhan Corp
  8.18.1 Company Details
  8.18.2 Product Information
  8.18.3 Yuhan Corp IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.18.4 Main Business Overview
  8.18.5 Yuhan Corp News
8.19 Actavis Nordic
  8.19.1 Company Details
  8.19.2 Product Information
  8.19.3 Actavis Nordic IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.19.4 Main Business Overview
  8.19.5 Actavis Nordic News
8.20 Ironwood Pharmaceuticals
  8.20.1 Company Details
  8.20.2 Product Information
  8.20.3 Ironwood Pharmaceuticals IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.20.4 Main Business Overview
  8.20.5 Ironwood Pharmaceuticals News
8.21 The Menarini Group
  8.21.1 Company Details
  8.21.2 Product Information
  8.21.3 The Menarini Group IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.21.4 Main Business Overview
  8.21.5 The Menarini Group News
8.22 Ono Pharmaceutical
  8.22.1 Company Details
  8.22.2 Product Information
  8.22.3 Ono Pharmaceutical IBS-C Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.22.4 Main Business Overview
  8.22.5 Ono Pharmaceutical News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX
LIST OF TABLES AND FIGURES

Figure IBS-C Drug Picture
Figure Research Programs/Design for This Report
Figure Global IBS-C Drug Market by Regions (2019)
Table Global Market IBS-C Drug Comparison by Regions (M USD) 2019-2025
Table Global IBS-C Drug Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of IBS-C Drug by Type in 2019
Figure Linaclotide Picture
Figure Lubiprostone Picture
Figure Osmotic Laxatives Picture
Figure Stimulant Laxatives Picture
Figure Other Picture
Table Global IBS-C Drug Sales by Application (2019-2025)
Figure Global IBS-C Drug Sales Market Share by Application in 2019
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global IBS-C Drug Sales by Manufacturer (2018-2020)
Figure Global IBS-C Drug Sales Market Share by Manufacturer in 2019
Table Global IBS-C Drug Revenue by Manufacturer (2018-2020)
Figure Global IBS-C Drug Revenue Market Share by Manufacturer in 2019
Table Global IBS-C Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 IBS-C Drug Manufacturer (Revenue) Market Share in 2019
Figure Top 10 IBS-C Drug Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into IBS-C Drug Market
Table Key Manufacturers IBS-C Drug Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of IBS-C Drug
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global IBS-C Drug Sales (K Units) by Region (2015-2020)
Table Global IBS-C Drug Sales Market Share by Region (2015-2019)
Figure Global IBS-C Drug Sales Market Share by Region (2015-2019)
Figure Global IBS-C Drug Sales Market Share by Region in 2018
Table Global IBS-C Drug Revenue (Million US$) by Region (2015-2020)
Table Global IBS-C Drug Revenue Market Share by Region (2015-2020)
Figure Global IBS-C Drug Revenue Market Share by Region (2015-2020)
Figure Global IBS-C Drug Revenue Market Share by Region in 2019
Table Global IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America IBS-C Drug Sales (K Units) Growth Rate (2015-2020)
Table North America IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe IBS-C Drug Sales (K Units) Growth Rate (2015-2020)
Table Europe IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan IBS-C Drug Sales (K Units) Growth Rate (2015-2020)
Table Japan IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China IBS-C Drug Sales (K Units) Growth Rate (2015-2020)
Table China IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global IBS-C Drug Sales by Type (2015-2020)
Table Global IBS-C Drug Sales Market Share by Type (2015-2020)
Figure Global IBS-C Drug Sales Market Share by Type in 2019
Table Global IBS-C Drug Revenue by Type (2015-2020)
Table Global IBS-C Drug Revenue Market Share by Type (2015-2020)
Figure Global IBS-C Drug Revenue Market Share by Type in 2019
Figure Global Linaclotide Sales Growth Rate (2015-2020)
Figure Global Linaclotide Price (2015-2020)
Figure Global Lubiprostone Sales Growth Rate (2015-2020)
Figure Global Lubiprostone Price (2015-2020)
Figure Global Osmotic Laxatives Sales Growth Rate (2015-2020)
Figure Global Osmotic Laxatives Price (2015-2020)
Figure Global Stimulant Laxatives Sales Growth Rate (2015-2020)
Figure Global Stimulant Laxatives Price (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global IBS-C Drug Sales by Application (2015-2020)
Table Global IBS-C Drug Sales Market Share by Application (2015-2020)
Figure Global IBS-C Drug Sales Market Share by Application in 2019
Figure Global Hospital Pharmacies Sales Growth Rate (2015-2020)
Figure Global Retail Pharmacies Sales Growth Rate (2015-2020)
Figure Global Online Pharmacies Sales Growth Rate (2015-2020)
Figure Global IBS-C Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global IBS-C Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global IBS-C Drug Price and Trend Forecast (2020-2025)
Table Global IBS-C Drug Sales (K Units) Forecast by Region (2020-2025)
Figure Global IBS-C Drug Production Market Share Forecast by Region (2020-2025)
Figure North America IBS-C Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America IBS-C Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe IBS-C Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe IBS-C Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan IBS-C Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan IBS-C Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China IBS-C Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure China IBS-C Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Catalent Pharmaceuticals Solutions Company Profile
Figure IBS-C Drug Product Picture and Specifications of Catalent Pharmaceuticals Solutions
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Catalent Pharmaceuticals Solutions IBS-C Drug Market Share (2018-2020)
Table Catalent Pharmaceuticals Solutions Main Business
Table Catalent Pharmaceuticals Solutions Recent Development
Table Ardelyx Company Profile
Figure IBS-C Drug Product Picture and Specifications of Ardelyx
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ardelyx IBS-C Drug Market Share (2018-2020)
Table Ardelyx Main Business
Table Ardelyx Recent Development
Table Synergy Pharmaceuticals Company Profile
Figure IBS-C Drug Product Picture and Specifications of Synergy Pharmaceuticals
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Synergy Pharmaceuticals IBS-C Drug Market Share (2018-2020)
Table Synergy Pharmaceuticals Main Business
Table Synergy Pharmaceuticals Recent Development
Table Nestle Company Profile
Figure IBS-C Drug Product Picture and Specifications of Nestle
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Nestle IBS-C Drug Market Share (2018-2020)
Table Nestle Main Business
Table Nestle Recent Development
Table Astellas Pharmaceuticals Company Profile
Figure IBS-C Drug Product Picture and Specifications of Astellas Pharmaceuticals
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Astellas Pharmaceuticals IBS-C Drug Market Share (2018-2020)
Table Astellas Pharmaceuticals Main Business
Table Astellas Pharmaceuticals Recent Development
Table Abbott Laboratories Company Profile
Figure IBS-C Drug Product Picture and Specifications of Abbott Laboratories
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Abbott Laboratories IBS-C Drug Market Share (2018-2020)
Table Abbott Laboratories Main Business
Table Abbott Laboratories Recent Development
Table Teva Pharmaceutical Industries Company Profile
Figure IBS-C Drug Product Picture and Specifications of Teva Pharmaceutical Industries
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Pharmaceutical Industries IBS-C Drug Market Share (2018-2020)
Table Teva Pharmaceutical Industries Main Business
Table Teva Pharmaceutical Industries Recent Development
Table Novartis Pharma Company Profile
Figure IBS-C Drug Product Picture and Specifications of Novartis Pharma
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis Pharma IBS-C Drug Market Share (2018-2020)
Table Novartis Pharma Main Business
Table Novartis Pharma Recent Development
Table Sucampo Pharmaceuticals Company Profile
Figure IBS-C Drug Product Picture and Specifications of Sucampo Pharmaceuticals
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sucampo Pharmaceuticals IBS-C Drug Market Share (2018-2020)
Table Sucampo Pharmaceuticals Main Business
Table Sucampo Pharmaceuticals Recent Development
Table Synthetic Biologics Company Profile
Figure IBS-C Drug Product Picture and Specifications of Synthetic Biologics
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Synthetic Biologics IBS-C Drug Market Share (2018-2020)
Table Synthetic Biologics Main Business
Table Synthetic Biologics Recent Development
Table Norgine Company Profile
Figure IBS-C Drug Product Picture and Specifications of Norgine
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Norgine IBS-C Drug Market Share (2018-2020)
Table Norgine Main Business
Table Norgine Recent Development
Table Albireo Pharma Company Profile
Figure IBS-C Drug Product Picture and Specifications of Albireo Pharma
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Albireo Pharma IBS-C Drug Market Share (2018-2020)
Table Albireo Pharma Main Business
Table Albireo Pharma Recent Development
Table Bama-Geve Company Profile
Figure IBS-C Drug Product Picture and Specifications of Bama-Geve
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bama-Geve IBS-C Drug Market Share (2018-2020)
Table Bama-Geve Main Business
Table Bama-Geve Recent Development
Table Astrazeneca Company Profile
Figure IBS-C Drug Product Picture and Specifications of Astrazeneca
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Astrazeneca IBS-C Drug Market Share (2018-2020)
Table Astrazeneca Main Business
Table Astrazeneca Recent Development
Table Prometheus Laboratories Company Profile
Figure IBS-C Drug Product Picture and Specifications of Prometheus Laboratories
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Prometheus Laboratories IBS-C Drug Market Share (2018-2020)
Table Prometheus Laboratories Main Business
Table Prometheus Laboratories Recent Development
Table Salix Pharmaceuticals Company Profile
Figure IBS-C Drug Product Picture and Specifications of Salix Pharmaceuticals
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Salix Pharmaceuticals IBS-C Drug Market Share (2018-2020)
Table Salix Pharmaceuticals Main Business
Table Salix Pharmaceuticals Recent Development
Table Ferring BV Company Profile
Figure IBS-C Drug Product Picture and Specifications of Ferring BV
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ferring BV IBS-C Drug Market Share (2018-2020)
Table Ferring BV Main Business
Table Ferring BV Recent Development
Table Yuhan Corp Company Profile
Figure IBS-C Drug Product Picture and Specifications of Yuhan Corp
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Yuhan Corp IBS-C Drug Market Share (2018-2020)
Table Yuhan Corp Main Business
Table Yuhan Corp Recent Development
Table Actavis Nordic Company Profile
Figure IBS-C Drug Product Picture and Specifications of Actavis Nordic
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Actavis Nordic IBS-C Drug Market Share (2018-2020)
Table Actavis Nordic Main Business
Table Actavis Nordic Recent Development
Table Ironwood Pharmaceuticals Company Profile
Figure IBS-C Drug Product Picture and Specifications of Ironwood Pharmaceuticals
Table IBS-C Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ironwood Pharmaceuticals IBS-C Drug Market Share (2018-2020)
Table Ironwood Pharmaceuticals Main Business
Table Ironwood Pharmaceuticals Recent Development
Table of Appendix


More Publications